CN

Ru Yi Zhang


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Innovations of Ru Yi Zhang in Neural Myelin Sheath Treatments.

Introduction

Ru Yi Zhang is an inventor based in China, known for his contributions to the field of medicinal compounds. His work primarily focuses on the therapeutic applications of icariin and Epimedium flavonoids. These compounds are being explored for their potential in treating conditions related to neural myelin sheath impairments.

Latest Patents

Ru Yi Zhang has developed a patent titled "New Use Of Icariin And Epimedium Flavonoids Containing Icariin." This invention provides new uses for compounds of Formula I or Epimedium containing compounds of Formula I, Epimedium flavonoids, or extracts of Epimedium. The patent outlines their application in manufacturing medicaments aimed at treating, preventing, reducing, and relieving diseases and conditions associated with neural myelin sheath impairments. Additionally, it discusses the use of these materials in creating medicaments for relieving demyelination and promoting the repair of the myelin sheath.

Career Highlights

Ru Yi Zhang is affiliated with Xuanwu Hospital of Capital Medical University, where he conducts research and development in the field of medicinal chemistry. His work has contributed to the understanding of how specific compounds can aid in neurological health.

Collaborations

Ru Yi Zhang collaborates with Lin Lin Yin, who is also involved in research related to his field of expertise. Their partnership enhances the potential for innovative solutions in treating neurological conditions.

Conclusion

Ru Yi Zhang's innovative work in the application of icariin and Epimedium flavonoids represents a significant advancement in the treatment of neural myelin sheath impairments. His contributions to medicinal chemistry continue to pave the way for future research and development in this critical area of health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…